SELLAS Life Sciences Group, Inc.
SLS
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company whose core business involves the development of novel cancer immunotherapies. This drug development process inherently requires animal testing to satisfy regulatory safety and efficacy standards. The company’s SEC filings explicitly note that it and its contract research organizations (CROs) are required to comply with Animal Welfare Act requirements in the conduct of their preclinical studies. Cruelty Free Investors, a watchdog organization, categorizes SELLAS under “Animal Testing” in its database of companies that exploit animals. As a biotechnology firm with no marketed products, its entire valuation and pipeline are contingent on preclinical and clinical research activities that utilize animal models.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.